Thompson Davis & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Thompson Davis & Co’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$152K	Buy	880 +630	+252%	+$90.9K	0.33%	68
2018 Q2	$35K	Buy	+250	New	+$35.5K	0.08%	245
2015 Q1	–	Sell	-50	Closed	-$3K	–	1294
2014 Q4	$3K	Buy	+50	New	+$3.65K	﹤0.01%	1073
2014 Q2	–	Sell	-50	Closed	-$3K	–	888
2014 Q1	$3K	Buy	+50	New	+$2.97K	0.01%	721

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Thompson Davis & Co's GWPH Position: Q3 2018 in Review

Thompson Davis & Co increased its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 252% in Q3 2018, buying an estimated $90.9K and bringing the position to 880 shares worth $152K. The position accounts for 0.33% of the portfolio, ranked #68.

Thompson Davis & Co first reported a position in GWPH in Q1 2014 and has held it in 4 quarters since. 272 funds tracked by Wall St. Rank hold GWPH as of Q3 2018.

Thompson Davis & Co held 880 shares of GW Pharmaceuticals Plc American Depositary Shares worth $152K as of Q3 2018.
Thompson Davis & Co bought 630 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2018, an estimated $90.9K.
GW Pharmaceuticals Plc American Depositary Shares made up 0.33% of Thompson Davis & Co's portfolio in Q3 2018, its #68 holding.
Thompson Davis & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and has held it in 4 quarters since.
272 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.